Therapeutic Innovation and Regulatory Science
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 32.9% | 0.902 | Q1 | 81.0% |
| 2024 | 1.9 | Q3 | 32.9% | 0.815 | Q1 | 78.4% |
| 2023 | 2.0 | Q3 | 39.5% | 0.637 | Q1 | 72.8% |
| 2022 | 1.5 | Q4 | 21.6% | 0.387 | Q2 | 58.2% |
| 2021 | 1.3 | Q4 | 31.0% | 0.406 | Q2 | 60.7% |
| 2020 | — | — | 0.569 | Q2 | 70.2% | |
| 2019 | — | — | 0.396 | Q2 | 60.8% | |
| 2018 | — | — | 0.453 | Q2 | 62.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2168-4804
ISSN
2168-4790
region
Western Europe
coverage
1970, 1972, 1974-2006, 2008-2011, 2013-2026